Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
Cancer
|
December 31, 2015
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer
Steven H Lin, Ning Zhang, Joy Godby, et al.
Leukemia & Lymphoma
|
September 15, 2022
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents
Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini, et al.
Leukemia
|
November 21, 2021
Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies
Susan Bal, Ehsan Malek, Ankit Kansagra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2021
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
Luciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
American Journal of Hematology
|
June 22, 2022
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy
Susan Bal, Binod Dhakal, Rebecca W Silbermann, et al.
Blood Advances
|
February 18, 2025
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience
Steven R Hwang, Richard C Godby, Brianna J Negaard, et al.
Leukemia & Lymphoma
|
July 26, 2023
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen
Sydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, et al.
The Lancet. Haematology
|
September 30, 2023
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
Luciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
ACS Biomaterials Science & Engineering
|
January 16, 2026
3D Printed Biosponge Adsorbers for Capturing Toxic Chemotherapy Drugs <i>In Situ</i> in the Body
Hee Jeung Oh, Mariam S Aboian, Colin R Yee, et al.
British Journal of Cancer
|
June 7, 2024
Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features
Kevin D Arnold, Krystle L Ong, Gayathri Ravi, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
Cancer
|
December 31, 2015
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer
Steven H Lin, Ning Zhang, Joy Godby, et al.
Leukemia & Lymphoma
|
September 15, 2022
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents
Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini, et al.
Leukemia
|
November 21, 2021
Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies
Susan Bal, Ehsan Malek, Ankit Kansagra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2021
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
Luciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
American Journal of Hematology
|
June 22, 2022
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy
Susan Bal, Binod Dhakal, Rebecca W Silbermann, et al.
Blood Advances
|
February 18, 2025
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience
Steven R Hwang, Richard C Godby, Brianna J Negaard, et al.
Leukemia & Lymphoma
|
July 26, 2023
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen
Sydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, et al.
The Lancet. Haematology
|
September 30, 2023
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
Luciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
ACS Biomaterials Science & Engineering
|
January 16, 2026
3D Printed Biosponge Adsorbers for Capturing Toxic Chemotherapy Drugs <i>In Situ</i> in the Body
Hee Jeung Oh, Mariam S Aboian, Colin R Yee, et al.
British Journal of Cancer
|
June 7, 2024
Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features
Kevin D Arnold, Krystle L Ong, Gayathri Ravi, et al.
Page
of 16